Postmenopausal endometrial cancer
Endometrial cancer, also known as uterine body cancer, refers to malignant tumors that originate in the endometrium, most of which are adenocarcinomas. After menopause, women's ovarian function declines and eventually fails; as estrogen levels gradually decrease, immune function declines, leading to an increase in the incidence of endometrial cancer.
-
Site of disease:
Uterus -
Infectious :
Not contagious -
Frequent population:
More common in women over 50 years old -
Related symptoms:
Abnormal bleeding Increased vaginal discharge Pain Uterine bleeding Irregular vaginal bleeding -
Concurrent disease:
Related Drugs
Hexamethylmelamine capsules
Indication: This product is used for combined chemotherapy of ovarian cancer, SCLC, malignant lymphoma, and endometrial cancer, and is particularly effective for ovarian cancer and SCLC.
Manufacturer:
ZHONGFU Pharmaceutical Co., Ltd.
Medroxyprogesterone acetate tablets
Indication: It can be used for irregular menstruation, functional uterine bleeding and endometriosis, etc. It can also be used for advanced breast cancer and endometrial cancer.
Manufacturer:
Zhejiang Xianju Pharmaceutical Co., Ltd.
Hexamethylmelamine tablets
Indication: This product is used for combined chemotherapy of ovarian cancer, SCLC, malignant lymphoma, and endometrial cancer, and is particularly effective for ovarian cancer and SCLC.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.
Medroxyprogesterone acetate capsules
Indication: Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.
Manufacturer:
Nanjing Cuccess Pharmaceutical Co., Ltd.
Medroxyprogesterone acetate tablets
Indication: It can be used for irregular menstruation, functional uterine bleeding and endometriosis, etc. It can also be used for advanced breast cancer and endometrial cancer.
Manufacturer:
Zhejiang Xianju Pharmaceutical Co., Ltd.
Related Ingredients